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Abstract Protein-calorie malnutrition, otherwise known as
cachexia, is a common problem in children undergoing
chronic peritoneal dialysis (PD) and is a frequent source of
significant morbidity and mortality. Recent evidence sug-
gests that the main factors involved in the pathogenesis are
metabolic acidosis, a decreased response to anabolic
hormones, and chronic inflammation, associated with
hormonal imbalances and an increased metabolic rate.
Given the complexity and multifactorial nature of cachexia,
the assessment of nutritional status in children on PD
requires a complete history and physical examination;
assessment of dietary intake, biochemical indices, and
anthropometry; and possibly bioimpedance analysis and
combined score systems. Its management should likewise
be multidisciplinary and include ensuring an adequate
energy and protein intake; optimal metabolic control, with
the correction of acidosis, anaemia, and hyperparathyroid-
ism; an optimal (or at least adequate) dialysis dose; and, if
necessary, prescription of specific drugs such as recombi-
nant human growth hormone.
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Introduction
Protein-calorie malnutrition is common in children under-
going chronic peritoneal dialysis (PD) and is associated
with increased morbidity and mortality [1–6]. Although
many articles have been published, only a few evidence-
based data are available for the paediatric PD population:
the many issues still being debated include the best way of
assessing nutritional status, the criteria for a diagnosis of
cachexia, and the best available measures for preventing
and treating it.
The aim of this article is to discuss the most important
questions concerning the assessment and management of
nutrition in children on PD.
Definition
An adequate nutritional status can be defined as the
maintenance of a normal body composition and a normal
pattern of growth, whereas protein-calorie malnutrition can
be identified as the loss of muscle mass and protein stores.
However, there is still no agreement as to terminology:
malnutrition generally describes a condition due to inade-
quate intake of nutrients in which the metabolic rate is
usually reduced, fats are lost, and lean body mass initially
preserved. Furthermore, and most importantly, these abnor-
malities can be reversed by dietary supplements.
Unfortunately, this is not the case for patients with
chronic kidney disease (CKD). So, given the multifactorial
nature of this condition, some authors have proposed to use
the term cachexia to describe the typical abnormalities in
the nutritional status of this population. This is a condition
characterised by loss of lean body mass combined with
normal or even increased fat mass, high resting energy
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expenditure and inadequate response to nutrient supple-
mentation [7–11].
However, in clinical practice, the term cachexia has so
far been restricted to severely malnourished patients and, in
the literature, most articles still use the term malnutrition. In
this article, preference is given to the term cachexia, and the
term malnutrition is used only where aspects of altered
nutrient intake are concerned.
Causes of cachexia in children on PD
The pathogenesis of cachexia in patients on dialysis is
complex and multifactorial, as can be seen from the
following causes:
I Decreased nutrient intake
1 Uremic toxins
2 Abnormalities in hormones controlling energy
homeostasis (↑leptin, ghrelin)
3 Inadequate release and function of neurotransmit-
ters (↓neuropeptide Y, agouti-related peptide)
4 Resistance to anabolic hormones [insulin, insulin-
like growth factor-1 (IGF-1)]
5 Metabolic acidosis
6 Systemic inflammation [↑ interleukin (IL)-1, IL-8,
tumour necrosis factor-α (TNF-α)]
7 Inadequate diet and economic/psychosocial prob-
lems
8 Medications affecting food intake
9 Inadequate dialysis dose/decreased residual renal
function
10 Sense of fullness due to abdominal fluid content
II Increased nutrient losses
1 Dialysate protein and amino acid losses
2 Recurrent episodes of peritonitis
3 Urinary protein losses (dependent on primary renal
disease)






A detailed analysis of all of these factors is beyond the
scope of this article, but some issues deserve special
mention. Anorexia is very common in patients with end-
stage renal disease (ESRD) and may be due to an increase
of anorexigenic peptides (leptin, ghrelin) and proinflamma-
tory cytokines [interleukin (IL)-1, IL-8, tumour necrosis
factor (TNF)-α] and a decrease of orexigenic hypothalamic
neuropeptides (neuropeptide Y, agouti-related peptide) [8,
12–14]. This imbalance frequently causes reduction in
energy and protein intake. Moreover, cachexia of dialysed
patients arises as a result of a complex interplay of acidosis,
a decreased response to anabolic hormones [insulin,
insulin-like growth factor-1 (IGF-1)] and chronic inflam-
mation [7–9]. The mechanisms underlying the muscle-
protein breakdown are activation of specific proteases, such
as caspase-3, and the ubiquitin-proteasome system [10, 11,
15]. This new knowledge opens the way to the develop-
ment of specific drugs aimed at regulating the sense of
appetite or counteracting the molecular mechanisms in-
volved in muscle proteolysis.
Assessment of nutritional status
Careful assessment of nutritional status is essential to
identify the initial signs of cachexia. However, there is still
no agreement as to the appropriate frequency of such
assessments, which clearly depends on the age of the child:
according to the National Kidney Foundation Kidney
Disease Outcomes Quality Initiative (NKF KDOQI) nutri-
tional guidelines, the majority of nutritional parameters
should be assessed at least monthly in children aged
younger than 2 years and every 3–4 months in older
children. The complexity of the pathogenesis and clinical
picture of cachexia in children on PD means that many
indices should be considered, which can be grouped into
seven different areas of investigation [16–19].
Clinical and physical examination
A detailed history can be very informative, as children on
dialysis may be very different from each other in terms of
individual risk factors for protein-calorie malnutrition such
as age, duration of CKD and dialysis, primary renal disease
with proteinuria or water and sodium losses, possible
concomitant acute or chronic inflammatory diseases,
recurrent episodes of peritonitis and various other comor-
bidities such as multiple malformation syndromes, obesity
and cardiovascular disease. The children or their parents
should be asked about whether there have been any changes
in appetite, gastrointestinal problems such as nausea,
vomiting, diarrhoea, constipation or (in infants) gagging,
any swallowing difficulties or an inability to chew solids
and any changes in energy levels and activity when playing
or attending school. Physical observations should focus on
the condition of hair, teeth, tongue, skin, nails and breath,
the impression of preserved or wasted fat or protein mass,
dehydration or oedema and blood pressure. Thin hair,
yellowish teeth lacking in enamel, pale furrowed tongue
with scattered papillae on the surface, thin pale skin with
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sometimes bronze complexion and smelly fishy breath are
peculiar to severe cachexia. However, although important,
these are all subjective and should be considered late
indicators of cachexia.
Anthropometry
Anthropometric indices such as weight (W), height or
length (H), height velocity (HV), head circumference (HC)
and body mass index (BMI) are widely used in clinical
practice, but measuring skin-fold thicknesses and body
diameters requires special consideration. Direct measure-
ments of tricipital skin-fold thickness and arm circumfer-
ence can be used to calculate midarm muscle circumference
(MAMC), arm muscle area (AMA) and arm fat area (AFA)
by means of the following formula:
MAMC ¼ C  πT=10ð Þ;AMA ¼ 10C  πTð Þ2
.
4π;
A ¼ π=4ð Þ 10C=πð Þ2;AFA ¼ A AMA;
where C is midarm circumference (cm), T tricipital skin-
fold thickness (mm), and A area of the arm (mm2) [20]. The
anthropometric results should be compared with the
corresponding control values and expressed as standard
deviation scores (SDS) according to the following formula:
SDS ¼ ið Þ=SDi
where x is the individual patient value, xi the mean value of
the normal reference population and SDi the standard
deviation for normal controls. Age- and gender-specific
reference values are available for the main anthropometric
variables [20–25], but normal values stratified for pubertal
status and race are lacking, which can affect the interpre-
tation of anthropometric data [19]. Moreover, the use of
chronological age for standardisation of anthropometric
variables in patients on PD is questionable, given the
growth deficit often present in this population. Although
not formally proven, some form of correction for height age
would be advisable [19].
One major drawback of all anthropometric indices is their
lack of sensitivity in detecting mild and early alterations in
nutritional status, and the main limitations of the parameters
derived from skin-fold thickness are their poor reproducibil-
ity and the high degree of interobserver variability, because
minimal variations in the direct measurements lead to large
differences in the derived parameters [26, 27]. The key
recommendation is therefore that the measurements should
be made by the same person and at regular intervals.
Various authors have proposed predictive equations for
estimating fat-free mass and fat mass based on anthropo-
metric measures also in paediatric patients [28, 29].
Unfortunately, inaccurate estimates of body composition
both at the individual and group level compared with
estimates from dual-energy X-ray absorptiometry (DEXA)
and research methods have been reported with the use of
these equations [30–32].
Dietary interview and diary
As cachexia is frequently associated with reduced protein
and energy intakes, dietary assessment is a key step when
evaluating dialysed children: it may not be strictly
necessary for a final diagnosis of cachexia, but it does
allow the prompt recognition of a factor that can lead to
progressive decline in nutritional status. It is for this reason
that nutrient intake, as estimated by means of dietary recall
or by calculating the protein catabolic rate (PCR) was
included in the minimal nutritional assessment recommen-
ded by the KDOQI in 2000 [16]. However, the use of 24-
h dietary recall is by definition highly affected by the ability
of parents to remember food details and quantities
correctly; furthermore, the inability to identify day-to-day
variability and the frequent under- or overreporting of
dietary intake make the method insufficiently accurate to
provide useful information. A multiple-day food record is
obviously more precise than a dietary interview but requires
the cooperation of parents, who should be given detailed
instructions by a dietician. The duration of dietary diaries is
still a matter of debate, and the need to capture day-to-day
variability in nutrient intake by prolonging it should be
balanced against the risk of inaccurate reporting. A 3-day
diary is usually adequate, but the optimal duration should
be individualised on the basis of the compliance of parents
and children. The collected information should include
protein and calorie intake, as well as fluids, electrolytes,
fats and carbohydrates.
Biochemical parameters
Many biochemical parameters have been proposed as a
means of evaluating nutritional status in children and adults
on chronic PD, including visceral proteins (albumin,
prealbumin, retinol-binding protein, transferrin), serum
creatinine and creatinine kinetics, total and partial lympho-
cyte counts and standard biochemistry. The most frequently
used parameter in paediatric patients is serum albumin. A
survey of prevalence data from the six-state New England
area found that more than one third of the children with
ESRD undergoing chronic PD had serum albumin concen-
trations <2.9 g/dl [5]. Wong et al. studied 1,723 paediatric
patients and found that each 1 g/dl difference in serum
albumin at the start of dialysis was associated with a 54%
higher risk of death, even after adjusting for the glomerular
causes of the ESRD and other potentially confounding
variables [2]. However, serum albumin may also be
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influenced by fluid overload, chronic inflammation, urinary
losses and the hyperpermeable status of the peritoneal
membrane. Furthermore, whether hypoalbuminemia is
predictive of mortality regardless of inflammation is still
debated: according to the Hemodialysis (HEMO) Study,
albumin is independently associated with nutrition and
inflammation [33]. According to Yeun et al., the acute-
phase response (or the cause of it) is largely responsible for
the effect of hypoalbuminemia on mortality in HD patients
[34]. Other biochemical parameters that can indirectly
reflect nutritional status are haemoglobin and serum
creatinine that, like total protein and serum albumin, have
been found to be significantly lower in children on PD with
an abnormal anthropometry-bioimpedance analysis nutri-
tion (ABN) score than in those with a normal ABN score
[6]. Low serum haemoglobin and creatinine levels may
therefore indicate the need for a thorough nutritional
assessment.
Protein metabolism
Nitrogen balance (i.e. the difference between nitrogen
intake and nitrogen losses) is one of the most powerful
indices of metabolic status in patients on chronic dialysis.
However, assessment of nitrogen losses can be complicat-
ed, as it involves urinary, dialysate and faecal collections
and requires specific nitrogen measurements. We therefore
measured nitrogen losses in the dialysate, urine and faeces
of 23 children on chronic PD and elaborated a mathematical
model for estimating nitrogen losses on the basis of the
results of easily measurable laboratory dialysate and urine
indices:
TNe g=dayð Þ ¼ 0:03þ 1:138UNureaþ 0:99DNurea
þ 1:18BSAþ 0:965DNprotein;
where TNe is total estimated nitrogen losses, UN urine
nitrogen, DN dialysate nitrogen and BSA body surface area
[35]. One major limitation of nitrogen balance is that it only
indicates the balance between intake and losses at a given
time and therefore anabolic or catabolic tendencies rather
than nutritional status. Although steady-state total nitrogen
appearance is the standard means of indirectly assessing
dietary protein intake, only urea nitrogen appearance
(UNA) is usually readily available. In children on PD in
clinically stable conditions, UNA can be calculated from
the sum of dialysate urea nitrogen and urinary urea
nitrogen; in clinically unstable patients, changes in blood
urea nitrogen have to be added.
The PCR, which is also called protein nitrogen appear-
ance (PNA), can be calculated from UNA using specific
regression equations. It is a useful indicator of protein
intake in patients in steady state and more precise than the
dietary protein intake obtained from dietary recall. Howev-
er, it is still unclear whether the best formula for obtaining
PCR is the modified Borah equations suggested by the
KDOQI guidelines or that proposed by Mendley [36]. A
significant association between PNA and hospitalisation
and mortality has been reported for adult patients on
dialysis [37, 38]. No data are available for paediatric
patients.
Body mass and body composition
Many methods have been proposed for the assessment of
body composition, including DEXA, isotope dilution
techniques, total body nitrogen and densitometry. However,
as most of them are technically difficult, expensive and lead
to the risk of exposing children to radiation or invasive
procedures, they cannot be used on a regular basis.
Bioelectric impedance analysis (BIA) is a noninvasive,
not-so-expensive and rapid means of assessing body
composition at the bedside. Both single frequency and
multifrequency analyses are widely used to assess the dry
weight of children and adults on dialysis. The classic
single-frequency method (distal and tetrapolar) provides
two indices: resistance (R), which is considered to be an
index of hydration, and reactance (Xc), which reflects both
hydration and nutritional status. However, the interpretation
of these results is still debated.
The first approach is to obtain lean body mass from BIA
measurements. Many predictive equations have been
proposed as a means of estimating body compartments on
the basis of the R and Xc indices, but their use in clinical
practice is not advisable [28] because they are based on
assumptions that are not always true in children (such as
constant hydration), and independent parameters such as
height, weight and gender may account for as much as 80%
of the result.
An alternative approach, vector BIA (BIVA), uses the R/
Xc graph method: the R and Xc measurements are
normalised by the stature of the subject, and vectors are
plotted as points on the gender-specific 50th, 75th and 95th
tolerance ellipses calculated from the healthy reference
population. Changes in hydration are associated with
movements of the impedance vector along a line of action
lying parallel to the major axis of the reference tolerance
ellipses, and alterations in nutritional status are associated
with a shift that is parallel to the minor axis of the same
ellipses [39]. The reference intervals of the whole-body
impedance vector in Italian children have been determined
by means of a cross-sectional, multicentre study [40].
However, although vector analysis allows an assumption-
free assessment of tissue composition, more data is required
concerning the paediatric dialysis population. Furthermore,
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BIVA is not quantitative and seems to be unsuitable for
storing in a follow-up nutritional database.
A third approach consists of considering only the
measured parameters (R and Xc) and the indices directly
derived from them: phase angle (PA), which is calculated as
the arc tangent of Xc/R, and distance (D), which is
calculated as (PA×10+Xc)/21/2. Reactance, phase angle
and distance are all significantly lower in malnourished
patients than in normal subjects and correlate well with
other indices of nutritional status in children and adults. A
number of studies of mainly adult patients have demon-
strated a good correlation between BIA parameters and
morbidity and mortality [41]. In a study of children treated
with automated PD, we assessed anthropometric and BIA
parameters during the first 24 months of dialysis and found
that the BIA indices of Xc, PA and D were able to detect
alterations in body composition earlier than anthropometry
[42].
The best way to use BIA indices is to compare the
measured values directly with previous data relating to the
same patient, taking into account patient’s height increase,
or with data from a reference population. This approach is
very sensitive in identifying even subtle changes in body
composition. BIA parameters may be influenced by body
fluid content. In patients with an abnormal hydration status
(such as children on PD), it is often difficult to distinguish
whether the changes in bioelectrical values are due to
alterations in the amount of water or the amount of body
cell mass. However, there is no doubt that BIA is the most
widely used method of assessing body composition in
clinical practice worldwide and, with the above-mentioned
caveats, is recognised as a useful tool for monitoring
nutritional status in ESRD patients
Nutritional scores
As no gold standard has yet been established, only the use
of various assessments can facilitate more precise nutri-
tional monitoring. The Subjective Global Assessment
(SGA), which is proposed for adult patients on dialysis, is
a widely used nutritional status scoring system based on
medical history, physical examination and the physician’s
grading of muscle wasting, subcutaneous fat and oedema;
however, there is unfortunately no paediatric version [43,
44].
We recently proposed a nutritional score based on
anthropometry and BIA. The ABN score uses nine
noninvasive, inexpensive and reliable parameters (if mea-
sured by the same operator) that are easy to apply to both ill
and healthy children: height, weight, BMI, MAMC, AMA,
AFA, reactance, phase angle and distance [45]. All of these
indices are expressed as SDS using a 5-point scale and then
elaborated using a dedicated software programme to obtain
an ABN score that may vary from 3 to 15. To establish the
cutoff value between normal nutritional status and cachexia,
it was first applied to healthy children, and distribution
percentiles were calculated: an ABN score corresponding to
the 3rd percentile (10.33) was established as the lowest
limit of normality. In a large Italian multicentre cross-
sectional study, 48.8% of the children on PD were found to
have some degree of cachexia on the basis of their ABN
score [6]. Not only all the parameters included in the score
system but also serum albumin, haemoglobin and creatinine
were significantly lower in children with an ABN scores of
<10.33 than in those with an ABN scores of >10.33. The
criteria used to select the nine ABN parameters, their
application to a large healthy population and the first data
coming from children on PD suggest that this scoring
system may be useful in assessing the nutritional status of
paediatric patients with ESRD. The major drawback of such
a method is that it has been used so far in only one
paediatric centre, and further studies are required to confirm
the value of such observation.
In conclusion, although many indices have been pro-
posed for the diagnosis of cachexia, no gold standard yet
exists, and no single index can adequately reflect nutritional
status [19]. Nutritional assessments should therefore be
based on multiple methods whose results should be
integrated by the paediatric nephrology team to make a
comprehensive evaluation. According to the KDOQI guide-
lines, minimal nutritional assessments in adults on dialysis
should include a visceral protein, such as serum albumin, a
dietary interview or nPCR calculation, and an index of
body composition [16]. The KDOQI guidelines adapted for
children receiving maintenance dialysis include an estimate
of nutrient intake by dietary interview, diary or PNA
calculation, serum albumin and a complete anthropometric
and growth assessment [16, 17, 19].
Prevention and treatment of cachexia
Given the multifactorial etiopathogenesis of cachexia in
children on PD, it should be approached in a multidisci-
plinary manner based on different steps [46].
Dietary protein and calorie intake
The provision of adequate energy and protein intake is
obviously fundamental, but anorexia may make it difficult
in many cases. According to the KDOQI nutritional
guidelines, the initially prescribed dietary energy intake
for children on PD should be the recommended daily
allowance (RDA) for their chronological age [16]. The
calories derived from the glucose in the dialysate should
also be considered when calculating daily total energy
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intake, because glucose absorption increases calorie intake
by 7–10 kcal/kg per day [47]. Dietary prescriptions
exceeding the RDA for age do not seem to be associated
with any better outcomes in terms of albumin levels,
morbidity or mortality and are currently not justified.
The dietary energy prescription should be adjusted on
the basis of the child’s response. The KDOQI guidelines
emphasise the importance of providing an adequate amount
of nonprotein calories [16]: in a study of 31 dialysed
children, the height velocity SDS correlated positively with
total energy intake and negatively with daily protein intake
[48]. Similarly, Azocar et al. found that a high protein
intake seems to have a negative effect on acid-base status,
bone mineralisation and fat-free mass [49].
As far as adequate dietary protein intake (DPI) is
concerned, the possible losses of nitrogenous compounds
in the dialysate should be taken into account [35, 50].
Albumin accounts for the majority of protein losses, and
free amino acids for about 20% of total losses; but other
proteins are also found in the dialysate, including immu-
noglobulins, transferrin and opsonin. The amount of protein
loss is greatly affected by a series of factors, including
peritoneal membrane permeability and peritoneal surface
area, with proportionately higher losses being experienced
by younger (and therefore smaller) children [50]. Protein
losses of 100–300 mg/kg per day (approximately 10% of
DPI) have been reported in children on PD, regardless of
the treatment modality [50]. Episodes of peritonitis can lead
to much greater protein and amino acid losses.
Nitrogen balance has been used as a means of
determining adequate protein intake. We found that
school-aged children on PD require a DPI of 144% RDA
to obtain an estimated N balance of >50 mg/kg per day,
which is considered necessary for growth [51]. Table 1
shows energy and protein intake levels recommended by
the KDOQI Clinical Practice Guidelines for children
undergoing chronic dialysis who are in stable clinical
condition [16].
It is well known that chronic uraemia predisposes
patients to a maladaptive state of low protein turnover that
may be associated with a blunted response to high
metabolic needs. In the case of accelerated protein
degradation due to increased metabolic needs (for example,
induced by an acute illness or conditions of stress),
compensatory mechanisms such as increased protein
synthesis may not be adequate. It is therefore particularly
important to adjust calorie and protein provision during
such periods to compensate for the increased protein
degradation.
If spontaneous oral intake is inadequate, specific
nutritional intervention should be considered. The first
dietetic intervention is generally oral nutrient supplementa-
tion. Modular carbohydrate, fat and protein components can
be used in infancy to increase the caloric density of the
formula; in older children, energy and protein supplemen-
tation can be provided by modular components or com-
mercial enteral products in liquid or bar form.
Enteral nasogastric, transpyloric or gastrostomy tube
feeding should be considered in patients who fail to meet
their nutritional goals by the oral route alone. There are
conflicting results regarding the effectiveness of enteral
supplementation in improving growth and nutrition. Most
studies have reported an increase of height and mainly
weight during enteral nutrition [52–54]. Conley et al.
reported catch-up growth in 5/10 dialysed infants tube fed
with 156–210% of the protein RDA and 108–134% of the
energy RDA [52]. Ledermann et al. used a 30-month
enteral feeding program to treat 35 children with chronic
renal failure/ESRD (six on peritoneal dialysis) and con-
cluded that long-term enteral feeding prevents or reverses
weight loss and growth retardation, with significant catch-
up growth if started before the age of 2 years [53]. Ramage
et al. used gastrostomy feeding to treat 15 infants and older
children on PD and concluded that it facilitates weight gain
and arrests the decline in height SDS that is usually
observed in infants with ESRD [54]. On the contrary, the
results of a North American Pediatric Renal Trials and
Collaborative Studies (NAPRTCS) survey of the effective-
ness of supplemental feeding in 174 children aged younger
than 6 years at the start of dialysis found no differences in
weight or height SDS after 30 days, 6 months or 1 year of
dialysis between the children who received supplementary
feeds and those who did not [55]. However, limitations of
registry studies should be taken into account when
interpreting such data.
Table 1 Recommended energy and protein intakes for children on
peritoneal dialysis (PD) according to the National Kidney Foundation

















Males 11–14 55 1.7–1.8
15–18 45 1.4–1.5
18–21 40 1.3
Females 11–14 47 1.7–1.8
15–18 40 1.4–1.5
18–21 38 1.3
726 Pediatr Nephrol (2009) 24:721–730
When comparing the different techniques of enteral
nutrition, it is necessary to consider the advantages and
limitations of each one. Nasogastric tubes are well tolerated
and easy to insert, but their use may be complicated by
recurrent episodes of emesis and the need for frequent tube
replacement. Gastrostomy tubes or buttons are hidden
beneath clothing but are also associated with emesis, exit-
site infections, leakage and peritonitis [56]. Gastrojejunos-
tomy should be limited to children undergoing enteral tube
feeding when severe gastroesophageal reflux is not resolved
by medical therapy. Percutaneous endoscopic gastrostomy
(PEG) insertion following PD initiation carries a high risk
for fungal peritonitis and potential PD failure. In such
cases, open placement should be considered [57, 58].
Parents should be reassured that transition from a gastro-
stomy button to oral feeding following renal transplantation
is generally successful without any significant delay.
Intraperitoneal nutritional supplementation
Intraperitoneal amino acid supplementation is another
option for children on PD, although it has been used in
only a few paediatric patients and for short periods of time
[59–61]. A Canadian randomised crossover study treated
seven children for 3 months each with an amino-acid-
supplemented dialysis solution and a standard dextrose
solution and found no statistically significant between-
period differences in terms of anthropometric parameters,
total body nitrogen or questionnaire-based appetite scores
[62]. Brem et al. reported the case of a 5-year-old PD
patient treated for 1 year with a balanced 1.1% amino
acid solution, whose serum albumin levels normalised
and who showed significant increases in appetite, weight
and linear growth velocity [63]. Some benefits in
nutritional status, albumin levels and survival have been
reported in adults on PD receiving intraperitoneal amino
acids [64, 65]. Based on these experiences, it seems
advisable to give PD-treated children with severe malnu-
trition a trial with an amino-acid-based PD solution
together with the other nutritional measures. However,
more studies are needed to better clarify the role of
intraperitoneal amino acid supplementation in improving
the nutritional status of children on PD.
Pharmacological intervention
The use of dietary and pharmacological interventions to
correct metabolic abnormalities (particularly acidosis, elec-
trolyte abnormalities, anaemia and hyperparathyroidism)
and treat complications such as infections and hypertension
is very important in preventing and treating cachexia. Given
the important role of drugs in controlling the blood
chemistry of children with ESRD and the complications
of uraemia mentioned above, particular monitoring is
required to ensure the correct administration and timing
of medications. Noncompliance with drug prescription is
a common problem in chronic dialysis patients, particu-
larly adolescents, and must be tackled by a collaborative
effort of the multidisciplinary team [66]. The side effects
of many drugs on the gastrointestinal tract should be taken
into account, as they may negatively influence oral food
intake.
Recombinant human growth hormone (rhGH) is one
option to increase height velocity in children with CKD,
being utilised in about 20–30% of children on dialysis, but
its role in preserving lean body mass and improving whole-
body protein homeostasis is not known in detail. Stefanidis
showed an improvement in nitrogen balance and a
significant increase in serum creatinine and creatinine
excretion (with stable weekly creatinine clearance) in nine
children on PD treated with rhGH, as well as an
improvement in MAMC, the pattern of plasma amino acids
and serum albumin [67]. A small number of studies of
uremic adults suggest that rhGH is associated with a strong
and sustained anabolic reaction and has a beneficial effect
on nutritional status. On the basis of these data, the use of
rhGH is advisable in selected children on PD with cachexia
with the aim of improving not only growth but also
nutritional status.
As regards other specific drugs for the treatment of
protein-calorie malnutrition, megestrol acetate is the most
extensively studied appetite stimulant. This drug has been
shown to improve appetite and nutritional status in adults
on hemodialysis, but the treatment may be risky and must
be closely monitored [68, 69]. Efficacy and safety of
nandrolone decanoate, an androgen derivative, have also
been investigated in adults with CKD. Although an
anabolic effect on lean body mass has been demonstrated,
more studies are needed to confirm such observation [70].
To the best of our knowledge, no studies tested these drugs
in paediatrics.
Given the association between proinflammatory cyto-
kines and cachexia in patients on dialysis, various anti-
inflammatory strategies have been proposed. It is worth
noting, for example, that some drugs commonly used in
patients with CKD, such as statins and angiotensin-
converting enzyme inhibitors, possess an anti-inflammatory
effect.
Given our ever-increasing knowledge about the patho-
genesis of cachexia in patients with CKD, it can be
expected that new drugs will be designed with the aim of
specifically counteracting the molecular abnormalities
(hormones, cytokines, neuropeptides) involved in nutrition-
al status impairment. New and promising therapeutic
interventions could be subcutaneous ghrelin administration
and melanocortin receptor antagonists.
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Dialysis dose and maintenance of residual renal function
A close relationship has been found between dialysis dose
and nutritional status, and that dialysis prescription (dialysis
dose, dialysis solutions, ultrafiltration) and residual renal
function should be monitored at least monthly. Peritoneal
clearance should be regularly assessed by means of 24-
h fluid collections and peritoneal membrane function by
means of the peritoneal equilibration test. Kt/V and/or
creatinine clearance data should be compared with the
dialysis dose requirements laid down in the KDOQI
guidelines [71], but they should only be used as indicators
of prescription adequacy, because other clinical aspects may
be more informative, such as control of uremic complica-
tions and growth itself [72]. The possibility of improving
nutritional status by increasing the dialysis dose is still
being debated, as there have been conflicting results
concerning the relationship between the parameters of
dialysis adequacy and nutritional indices in both adult and
paediatric patients. The very definition of optimal dialysis
is still controversial, but what is certain is that a PD dose of
at least that recommended by the KDOQI guidelines is
needed [73]. On the basis of these findings, the search for
optimal dialysis dosing and nutritional intake is warranted.
Conclusions
Despite recent advances in our knowledge of the mecha-
nisms causing cachexia, both its early diagnosis and
optimal treatment remain an open challenge. The prompt
identification of cases of mild nutritional impairment
requires the frequent monitoring of all of the physical,
biochemical and instrumental signs of cachexia. Without a
comprehensive evaluation of all indices, any conclusion
about the nutritional status of a patient may be misleading.
As regards the treatment of malnutrition, further studies
are needed to clarify the molecular abnormalities involved
and determine specific treatment strategies. In the mean-
time, multidisciplinary efforts by physicians, dieticians,
psychologists, nurses and parents are needed in an attempt
to optimise every aspect of care. Such a common effort
alone could prevent children from losing muscle mass and
protein stores and thus allow better growth, reduced
morbidity and a better quality of life.
Questions
(Answers appear following the reference list)
1. Which one of the following methods can be considered
as a gold standard for the diagnosis of protein-calorie
malnutrition in children on peritoneal dialysis?
a. Bioimpedance analysis
b. Dual-energy X-ray absorptiometry
c. Serum albumin
d. Total body potassium
e. None
2. Anorexia in children with ESRD is due to:
a. Decreased leptin levels
b. Increased neuropeptide-Y levels
c. Increased proinflammatory cytokines levels
d. a+b+c
3. The recommended dietary calorie intake for a 5-year-
old child on peritoneal dialysis according to the NKF
KDOQI guidelines should be:
a. 50 kcal/kg per day
b. 70 kcal/kg per day
c. 90 kcal/kg per day
d. 110 kcal/kg per day
e. 130 kcal/kg per day
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